| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/12/2022 | 127.27% | Credit Suisse | → $10 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 809.09% | Canaccord Genuity | → $40 | Initiates Coverage On | → Buy |
Mynaric Questions & Answers
The latest price target for Mynaric (NASDAQ: MYNA) was reported by Credit Suisse on October 12, 2022. The analyst firm set a price target for $10.00 expecting MYNA to rise to within 12 months (a possible 127.27% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Mynaric (NASDAQ: MYNA) was provided by Credit Suisse, and Mynaric initiated their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mynaric, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mynaric was filed on October 12, 2022 so you should expect the next rating to be made available sometime around October 12, 2023.
While ratings are subjective and will change, the latest Mynaric (MYNA) rating was a initiated with a price target of $0.00 to $10.00. The current price Mynaric (MYNA) is trading at is $4.40, which is within the analyst's predicted range.